These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 35112483)

  • 41. Advances of microneedles in hormone delivery.
    Nguyen TT; Nguyen TTD; Tran NM; Vo GV
    Biomed Pharmacother; 2022 Jan; 145():112393. PubMed ID: 34773762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current advances in the fabrication of microneedles for transdermal delivery.
    Indermun S; Luttge R; Choonara YE; Kumar P; du Toit LC; Modi G; Pillay V
    J Control Release; 2014 Jul; 185():130-8. PubMed ID: 24806483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent Advances in Skin Penetration Enhancers for Transdermal Gene and Drug Delivery.
    Amjadi M; Mostaghaci B; Sitti M
    Curr Gene Ther; 2017; 17(2):139-146. PubMed ID: 28494734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug delivery systems. 6. Transdermal drug delivery.
    Ranade VV
    J Clin Pharmacol; 1991 May; 31(5):401-18. PubMed ID: 2050824
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Challenges and strategies in developing microneedle patches for transdermal delivery of protein and peptide therapeutics.
    Wu F; Yang S; Yuan W; Jin T
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1292-8. PubMed ID: 22201589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanoparticle delivery for transdermal HRT.
    Valenzuela P; Simon JA
    Nanomedicine; 2012 Sep; 8 Suppl 1():S83-9. PubMed ID: 22640909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current Updates in Transdermal Therapeutic Systems and Their Role in Neurological Disorders.
    Yadav N; Mittal A; Ali J; Sahoo J
    Curr Protein Pept Sci; 2021; 22(6):458-469. PubMed ID: 33183199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent Advances in Microneedle Platforms for Transdermal Drug Delivery Technologies.
    Mdanda S; Ubanako P; Kondiah PPD; Kumar P; Choonara YE
    Polymers (Basel); 2021 Jul; 13(15):. PubMed ID: 34372008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microneedles: A New Frontier in Nanomedicine Delivery.
    Larrañeta E; McCrudden MT; Courtenay AJ; Donnelly RF
    Pharm Res; 2016 May; 33(5):1055-73. PubMed ID: 26908048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microneedles: an emerging transdermal drug delivery system.
    Bariya SH; Gohel MC; Mehta TA; Sharma OP
    J Pharm Pharmacol; 2012 Jan; 64(1):11-29. PubMed ID: 22150668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microneedles and transdermal applications.
    Sivamani RK; Liepmann D; Maibach HI
    Expert Opin Drug Deliv; 2007 Jan; 4(1):19-25. PubMed ID: 17184159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanocrystals Technology for Transdermal Delivery of Water-Insoluble Drugs.
    Liu Y; Zhao J; Wang L; Yan B; Gu Y; Chang P; Wang Y
    Curr Drug Deliv; 2018; 15(9):1221-1229. PubMed ID: 29779482
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel approaches of the nanotechnology-based drug delivery systems for knee joint injuries: A review.
    Younas A; Gu H; Zhao Y; Zhang N
    Int J Pharm; 2021 Oct; 608():121051. PubMed ID: 34454029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microneedles: a valuable physical enhancer to increase transdermal drug delivery.
    Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Molina-Trinidad E; Casas-Alancaster N; Revilla-Vázquez AL
    J Clin Pharmacol; 2011 Jul; 51(7):964-77. PubMed ID: 21148047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Strategies for transdermal drug delivery against bone disorders: A preclinical and clinical update.
    Sharma G; Alle M; Chakraborty C; Kim JC
    J Control Release; 2021 Aug; 336():375-395. PubMed ID: 34175368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transdermal drug delivery: feasibility for treatment of superficial bone stress fractures.
    Aghazadeh-Habashi A; Yang Y; Tang K; Lőbenberg R; Doschak MR
    Drug Deliv Transl Res; 2015 Dec; 5(6):540-51. PubMed ID: 26350235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent advances in gel technologies for topical and transdermal drug delivery.
    Rehman K; Zulfakar MH
    Drug Dev Ind Pharm; 2014 Apr; 40(4):433-40. PubMed ID: 23937582
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advanced progress of microencapsulation technologies: in vivo and in vitro models for studying oral and transdermal drug deliveries.
    Lam PL; Gambari R
    J Control Release; 2014 Mar; 178():25-45. PubMed ID: 24417967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.